Search For "nafld"
Disruption In India's Wellness Market: dLife Introduces 'Reverse Or Refund
Updated : 2 months, 1 week ago IST
New Delhi [India], March 6: India's chronic lifestyle disease management playbook has traditionally focused on lifelong management through medicines and medical procedures. Patients are advised to control their numbers, stay on medication, and accept metabolic conditions as permanent. So muc
Read More
Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Wo
Updated : 9 months, 1 week ago IST
Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world's first regulatory approval from India's Central Drugs Standard Control Organization (CDSCO) f
Read More
Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets
Updated : 1 year, 2 months ago IST
Raichur (Karnataka) [India], March 12: Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug (IND) - Nor Ursodeoxycholic Acid (Nor UDCA) Tablets
Read More
Zydus and Lupin Sign Licensing Agreement for Co-Marketing Saroglitazar Mg,
Updated : 2 years, 6 months ago IST
Ahmedabad (Gujarat) [India], November 3: Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as "Zydus") a discovery-driven, global lifesciences company and Lupin Limited (Lupin), a global pharma major, today announced that they have entered into a licensi
Read More
Study indicates how resistant starch consumption decreases liver triglycer
Updated : 7 months, 3 weeks ago IST
Resistant starch is a nondigestible fibre that ferments in the large intestine and has previously been found to boost metabolism in animal tests. A 4-month randomised controlled experiment in persons with non-alcoholic fatty liver disease (NAFLD) found that regularly eating resistant starch
Read More
Study finds how intake of resistant starch reduces liver triglycerides in
Updated : 2 years, 8 months ago IST
Resistant starch is a nondigestible fibre that ferments in the large intestine, and it has previously been demonstrated in animal experiments to have a favourable effect on metabolism. A 4-month randomised controlled experiment in persons with non-alcoholic fatty liver disease (NAFLD) has fo
Read More
Health Ministry organizes webinar for medical officers of PHCs, district h
Updated : 2 years, 11 months ago IST
The Union Ministry of Health and Family Welfare on Thursday organized a webinar on Non-Alcoholic Fatty Liver Diseases (NAFLD) to empower medical officers of Primary Health Centres (PHCs), Community Health Centres (CHCs) and District Hospitals.
Read More
Increasing coffee consumption may lower the severity of non-alcoholic fatt
Updated : 3 years, 4 months ago IST
A new study, published in Nutrients, from the University of Coimbra discovered that caffeine, polyphenols, and other natural compounds contained in coffee may help lower the severity of non-alcoholic fatty liver disease (NAFLD) in overweight adults with type 2 diabetes (T2D).
Read More
Research: Potential new targets identified in non-alcoholic fatty liver di
Updated : 3 years, 4 months ago IST
Researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease (NAFLD) by using the latest technologies, including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells
Read More
Fatty liver disease adversely affects brain health: Study
Updated : 3 years, 5 months ago IST
Scientists at the Roger Williams Institute of Hepatology, affiliated with King's College London and the University of Lausanne, discovered in a study examining the link between non-alcoholic fatty liver disease (NAFLD) and brain dysfunction that an accumulation of fat in the liver causes a d
Read More
Non-heavy alcohol use associated with liver fibrosis: Study
Updated : 3 years, 5 months ago IST
According to a new study, non-heavy alcohol use on liver health are often contradictory, both within the general population and among those known to have non-alcoholic fatty liver disease (NAFLD) and at-risk individuals.
Read More
First-degree relatives of patients with NAFLD at risk of liver disease: Re
Updated : 3 years, 5 months ago IST
Approximately one-fourth of the general population worldwide has nonalcoholic fatty liver disease, known as NAFLD, an umbrella term for a range of liver conditions affecting people who drink little to no alcohol. NAFLD can lead to cirrhosis, liver cancer and liver failure.
Read More